Your account is not claimed yet. You can sign up with ORCID to claim your account.

Volker Vallon

Years Active: 2019-2022
Publications (10 Years): 7

University of California San Diego

University of Tuebingen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Diego Oct 1o 2003

United States

Professor of Medicine in Residence; Adjunct Professor of Pharmacology

Education History

University of Tuebingen

Germany

PHD

Publications

Takahiro Masuda, Ken Ohara, Volker Vallon, Daisuke Nagata
SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats. American journal of physiology. Renal physiology 323 (3) (2022)
Volker Vallon, Young Chul Kim
Protecting the Kidney: The Unexpected Logic of Inhibiting a Glucose Transporter. Clinical pharmacology and therapeutics 112 (3) (2022)
Aleix Navarro Garrido, Young Chul Kim, Yuji Oe, Haiyan Zhang, Maria Crespo-Masip, Helen A Goodluck, Sadhana Kanoo, Paul W Sanders, Stefan Broer, Volker Vallon
Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B 0 AT1 ( Slc6a19 ). American journal of physiology. Renal physiology 323 (4) (2022)
Hermann Koepsell, Volker Vallon
A special issue on glucose transporters in health and disease. Pflugers Archiv : European journal of physiology 472 (9) (2020)
Volker Vallon
Glucose transporters in the kidney in health and disease. Pflugers Archiv : European journal of physiology 472 (9) (2020)
Volker Vallon, Scott C Thomson
The tubular hypothesis of nephron filtration and diabetic kidney disease. Nature reviews. Nephrology 16 (6) (2020)
Hadi Fattah, Volker Vallon
The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus. Drugs 78 (7) (2019)

Volker Vallon.css-eqlu8i{font-size:small;padding-left:4px;}